Nitric oxide is a mediator of the late-phase response in an animal model of nasal allergy

Otolaryngology-Head and Neck Surgery

Volumn 122, Issue 5, 2000, Pages 706-711

  Durland, William F ^a   Lane, Andrew P ^a   Durland, Kimberly W ^b   Smith, Timothy L ^c   Johnson, Kenneth L ^a   Prazma, Jiri ^a   Pillsbury, Harold C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b GLAXOSMITHKLINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OVALBUMIN;

ALLERGIC RHINITIS; ALLERGY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; INFLAMMATORY CELL; LAVAGE; NONHUMAN; RAT; RHINITIS;

ALBUMINS; ALLERGENS; ANIMALS; ENZYME INHIBITORS; HISTAMINE; INFLAMMATION MEDIATORS; NASAL LAVAGE FLUID; NASAL MUCOSA; NASAL PROVOCATION TESTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OVALBUMIN; PASSIVE CUTANEOUS ANAPHYLAXIS; RATS; RATS, INBRED BN; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0034088695     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1067/mhn.2000.104015     Document Type: Article

References (27)

1. Hadley JA. Overview of otolaryngic allergy management. Otolaryngol Clin North Am 1998; 35: 69–82
2. Furukawa K, Harrison DG, Saleh D, et al. Expression of nitric oxide synthase in the human nasal mucosa. Am J Respir Crit Care Med 1996; 153: 847–50
3. Hanazawa T, Konno A, Kaneko T, et al. Nitric oxide synthase-immunoreactive nerve fibers in the nasal mucosa of the rat. Brain Res 1994; 657: 7–13
4. Kulkarni A, Getchell TV, Getchell ML. Neuronal nitric oxide synthase is localized in extrinsic nerves regulating perireceptor processes in the chemosensory nasal mucosa of rats and humans. J Comp Neurol 1994; 345: 125–38
5. Schedin U, Frostell C, Persson MG, et al. Contribution from upper and lower airway to exhaled endogenous nitric oxide in humans. Acta Anaesthesiol Scand 1995; 39: 327–32
6. Kimberly B, Nejadnik B, Giraud GD, et al. Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans. Am J Respir Crit Care Med 1996; 153: 829–36
7. Arnal JF, Didier A, Rami J, et al. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 1997; 27: 358–62
8. Martin U, Bryden K, Devoy M, et al. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996; 97: 768–72
9. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368–70
10. Lane AP, Prazma J, Baggett HC, et al. Nitric oxide is a mediator of neurogenic vascular exudation in the nose. Otolaryngol Head Neck Surg 1997; 116: 294–300
11. Dear JW, Scadding GK, Foreman JC. Reduction by N-nitro-L-arginine methyl ester (L-NAME) of antigen-induced nasal airway plasma extravasation in human subjects in vivo. Br J Pharmacol 1995; 116: 1720–2
12. Morita H, Hori M, Kitano Y. Modulation of picryl chloride—induced contact hypersensitivity reaction in mice by nitric oxide. J Invest Dermatol 1996; 107: 549–52
13. Salvemini D, Wang ZQ, Wyatt PS, et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996; 118: 829–38
14. Uchida Y, Endo T, Iijima H, et al. Increased production of nitric oxide in the immediate and late asthmatic responses in models of guinea pig experimental asthma. Jpn J Thorac Dis 1995; 33: 190–2
15. Watanabe A, Mishima H, Renzi PM, et al. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats. J Clin Invest 1995; 96: 1303–10
16. Watanabe N, Ovary Z. Antigen and antibody detection by in vivo methods: a reevaluation of passive cutaneous anaphylactic reactions. J Immunol Methods 1977; 14: 381–90
17. Ordronneau P, Abdullah LH, Petrusz P. An efficient enzyme immunoassay for glutamate using glutaraldehyde coupling of the hapten to microtiter plates. J Immunol Methods 1991; 142: 169–76
18. Meijer F, Ruijter JM, Van Delft JL, et al. Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva. Eur J Pharmacol 1995; 284: 61–7
19. Miura M, Ichinose M, Kegeyama N, et al. Endogenous nitric oxide modifies antigen-induced microvascular leakage in sensitized guinea pig airways. J Allergy Clin Immunol 1996; 98: 144–51
20. Ali H, Haribabu B, Richardson RM, et al. Mechanisms of inflammation and leukocyte activation. Med Clin North Am 1997; 81: 1–28
21. Remick DG, Villarete L. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J Leukocyte Biol 1996; 59: 471–5
22. Naclerio RM. Pathophysiology of perennial allergic rhinitis. Allergy 1997; 52 (36 Supplement): 7–13
23. Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 1997; 53: 576–82
24. Gronneberg R, Zetterstrom O. Inhibition of the late phase response to anti-IgE in humans by indomethacin. Allergy 1985; 40: 36–41
25. Cartwright JE, Whitley GS, Johnstone AP. Endothelial cell adhesion molecule expression and lymphocyte adhesion to endothelial cells: effect of nitric oxide. Exp Cell Res 1997; 235: 431–4
26. De Caterina R Libby P Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60–68
27. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994; 74: 1133–40